4//SEC Filing
Benathen Marc David 4
Accession 0001362118-23-000047
CIK 0000948320other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 12:02 PM ET
Size
14.8 KB
Accession
0001362118-23-000047
Insider Transaction Report
Form 4
LifeMD, Inc.LFMD
Benathen Marc David
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-27+25,000→ 77,554 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-07-11−200,000→ 0 totalExercise: $21.20→ Common Stock (200,000 underlying) - Exercise/Conversion
Restricted Stock
2023-01-27−25,000→ 25,000 total→ Common Stock (25,000 underlying) - Exercise/Conversion
Restricted Stock
2023-07-11−25,000→ 0 total→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2023-07-11+25,000→ 227,554 total - Award
Common Stock
2023-07-11+125,000→ 202,554 total
Footnotes (3)
- [F1]The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.
- [F2]Restricted stock converts into common stock on a one-for-one basis.
- [F3]Restricted stock vested on January 27, 2023.
Documents
Issuer
LifeMD, Inc.
CIK 0000948320
Entity typeother
Related Parties
1- filerCIK 0001845258
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 12:02 PM ET
- Size
- 14.8 KB